Chemed (CHE) Short term Debt (2013 - 2023)

Chemed (CHE) recorded quarterly Short term Debt of $5.0 million in Q1 2023, little changed quarter-over-quarter from $5.0 million in Q4 2022.

Chemed (CHE) Short term Debt (2013 - 2023) Analysis & Trends

Chemed's Short term Debt history runs 8 years deep, the most recent figure standing at $5.0 million for Q1 2023.

In Q1 2023, Short term Debt changed N/A year-over-year to $5.0 million; the TTM figure through Mar 2023 stood at $5.0 million (changed N/A YoY), while the FY2022 annual figure was $5.0 million, changed N/A from the prior year.
Short term Debt was $5.0 million for Q1 2023 at Chemed, roughly flat from $5.0 million in the prior quarter.
In the past five years, Short term Debt ranged from a high of $5.0 million in Q2 2022 to a low of $5.0 million in Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	HCA Healthcare	83.85 Bn	86.23 Bn	16.26 Bn
2	Tenet Healthcare	14.98 Bn	14.15 Bn	4.41 Bn
3	Davita	13.99 Bn	14.84 Bn	1.07 Bn
4	Encompass Health	9.72 Bn	10.34 Bn	1.34 Bn
5	Ensign	8.90 Bn	8.31 Bn	293.37 Mn
6	Universal Health Services	8.59 Bn	8.55 Bn	3.21 Bn
7	Fresenius Medical Care AG	7.67 Bn	5.29 Bn	-4.26 Bn
8	Chemed	5.97 Bn	5.96 Bn	215.76 Mn
9	Pacs	5.74 Bn	5.50 Bn	345.96 Mn
10	Concentra Group Holdings Parent	3.59 Bn	3.54 Bn	170.47 Mn

Download Data